Enzo J. Vialardi
Plus aucun poste en cours
Profil
Mr. Vialardi has been an Executive Vice President of Del since 1998 and is a member of the Executive Committee.
He had previously been Senior Vice President, Finance and Operations for Del from 1991 until 1996 when he left the company to become Chief Operating Officer for Nice-Pak Products, Inc. From 1996 to 1998, Mr. Vialardi was a consultant to pharmaceutical and consumer goods manufacturers and retailers.
Prior to joining Del for the first time in 1991, Mr. Vialardi held a number of executive positions at Revlon, Inc., Simon & Schuster, Inc. and PepsiCo, Inc. Mr. Vialardi began his career as a Certified Public Accountant with Deloitte, Haskins & Sells.
Anciens postes connus de Enzo J. Vialardi
| Sociétés | Poste | Fin |
|---|---|---|
Del Laboratories, Inc.
 Del Laboratories, Inc. Household/Personal CareConsumer Non-Durables Del Laboratories, Inc. is a leading developer, manufacturer, and marketer of cosmetics and over the counter pharmaceuticals. Its product portfolio is comprised of several market leading brands, including Sally Hansen, La Cross, N.Y.C. New York Color, and Orajel. Del enjoys leadership positions in the nail care, bleaches & depilatories, and oral analgesics categories. Del's market leading positions have been achieved due to the treatment benefits associated with most of its products and its product innovation. Del generates a majority of its revenues from products that are leaders in their respective categories. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Del Laboratories, Inc.
Del Laboratories, Inc. Household/Personal CareConsumer Non-Durables Del Laboratories, Inc. is a leading developer, manufacturer, and marketer of cosmetics and over the counter pharmaceuticals. Its product portfolio is comprised of several market leading brands, including Sally Hansen, La Cross, N.Y.C. New York Color, and Orajel. Del enjoys leadership positions in the nail care, bleaches & depilatories, and oral analgesics categories. Del's market leading positions have been achieved due to the treatment benefits associated with most of its products and its product innovation. Del generates a majority of its revenues from products that are leaders in their respective categories. | Consumer Non-Durables |
